Moffitt logo

Clinical Trials Search

Search Results:

Showing of 50

CLINICAL TRIAL 20015

Change in Relative Cerebral Blood Volume as a Biomarker for Early Response to Bevacizumab in Patients with Recurrent Glioblastoma

Cancer Type: Neurologic Oncology

View Trial Details

CLINICAL TRIAL 19956

A Phase 1b Trial of CB-839 in Combination with Radiation Therapy and Temozolomide in Patients with IDH-mutated Diffuse Astrocytoma and Anaplastic Astrocytoma

Cancer Type: Neurologic Oncology

View Trial Details

CLINICAL TRIAL 19648

Phase IB Study of Avelumab with Radiotherapy in Patients with Leptomeningeal Disease

Cancer Type: Neurologic Oncology

View Trial Details

CLINICAL TRIAL 18661

Phase I Trial of Hypofractionated Stereotactic Irradiation (HFSRT) Combined with Nivolumab, Ipilimumab and Bevacizumab in Patients with Recurrent High Grade Gliomas

Cancer Type: Neurologic Oncology

View Trial Details

CLINICAL TRIAL 20248

A Phase 1, Open-Label Study to Assess The Pharmacokinetics, Pharmacodynamics and Central Nervous System (CNS) Penetration of CC-90010 in Preoperative Subjects with Progressive or Recurrent who Grade II Diffuse Astrocytoma, Grade III Anaplastic Astrocytoma and Recurrent Glioblastoma Scheduled for Resection

Cancer Type: Neurologic Oncology

View Trial Details

CLINICAL TRIAL 19339

A Phase II Trial of AZD9291 (Osimertinib) with or without Bevacizumab in Patients with EGFR Mutation Positive NSCLC and Brain Metastases

Cancer Type: Neurologic Oncology

View Trial Details

CLINICAL TRIAL 20028

Phase III Trial of Observation Versus Irradiation for a Gross Totally Resected Grade II Meningioma

Cancer Type: Neurologic Oncology

View Trial Details

CLINICAL TRIAL 20110

GBM Agile: Global Adaptive Trial Master Protocol

Cancer Type: Neurologic Oncology

View Trial Details

CLINICAL TRIAL 19765

Phase Ib Study of Stereotactic Radiation and Nivolumab in the Management of Metastatic Breast Cancer Brain Metastases

Cancer Type: Breast

View Trial Details

CLINICAL TRIAL 20247

A Phase 2b Trial of the MEK 1/2 Inhibitor (MEKi) PD-0325901 in Adult and Pediatric Patients with Neurofibromatosis Type 1 (NF1)-Associated Inoperable Plexiform Neurofibromas (PNs) that are Causing Significant Morbidity

Cancer Type: Neurologic Oncology

View Trial Details

CLINICAL TRIAL 20027

A Phase III Trial of Stereotactic Radiosurgery Compared with Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) Plus Memantine for 5-15 Brain Metastases

Cancer Type: Neurologic Oncology

View Trial Details

CLINICAL TRIAL 18752

ACTION Trial- Adoptive Cellular Therapy following Dose-Intensified Temozolomide in Newly-diagnosed Pediatric High-grade Gliomas (Phase I)

Cancer Type: Neurologic Oncology

View Trial Details

CLINICAL TRIAL 19327

A Phase 2 Trial of Pembrolizumab Plus Bevacizumab in Patients with Metastatic Melanoma or Non-small Cell Lung Cancer with Untreated Brain Metastases

Cancer Type: Neurologic Oncology

View Trial Details

CLINICAL TRIAL 20022

Feasibility Study for Electroacupuncture for Chemotherapy- Induced Peripheral Neuropathy (CIPN) Using a Point-Of-Nerve Conduction Device (NeuroMetrix) and the Rydel-Seiffer Tuning Fork

Cancer Type: Gynecological Tumor

View Trial Details